|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brevik A, Joshi AD, Corral R, Onland-Moret
NC, Siegmund KD, Le Marchand L, Baron JA, Martinez ME, Haile RW,
Ahnen DJ, et al: Polymorphisms in base excision repair genes as
colorectal cancer risk factors and modifiers of the effect of diets
high in red meat. Cancer Epidemiol Biomarkers Prev. 19:3167–3173.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lynch PM: The hMSH2 and hMLH1 genes in
hereditary nonpolyposis colorectal cancer. Surg Oncol Clin N Am.
18:611–624. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shin MH, Holmes MD, Hankinson SE, Wu K,
Colditz GA and Willett WC: Intake of dairy products, calcium and
vitamin d and risk of breast cancer. J Natl Cancer Inst.
94:1301–1311. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sherr CJ: Cancer cell cycles. Science.
274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kaminagakura E, da Werneck Cunha I, Soares
FA, Nishimoto IN and Kowalski LP: CCND1 amplification and protein
overexpression in oral squamous cell carcinoma of young patients.
Head Neck. 33:1413–1419. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Troncone G, Volante M, Iaccarino A, Zeppa
P, Cozzolino I, Malapelle U, Palmieri EA, Conzo G, Papotti M and
Palombini L: Cyclin D1 and D3 overexpression predicts malignant
behavior in thyroid fine-needle aspirates suspicious for Hurthle
cell neoplasms. Cancer. 117:522–529. 2009.PubMed/NCBI
|
|
8
|
Abramson VG, Troxel AB, Feldman M, Mies C,
Wang Y, Sherman L, McNally S, Diehl A and Demichele A: Cyclin D1b
in human breast carcinoma and coexpression with cyclin D1a is
associated with poor outcome. Anticancer Res. 30:1279–1285.
2010.PubMed/NCBI
|
|
9
|
Zhang L, Chen LM, Wang MN, Chen XJ, Li N,
Huang YD and Chen M: The G894t, T-786c and 4b/a polymorphisms in
Enos gene and cancer risk: A meta-analysis. J Evid Based Med.
7:263–269. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Betticher DC, Thatcher N, Altermatt HJ,
Hoban P, Ryder WD and Heighway J: Alternate splicing produces a
novel cyclin D1 transcript. Oncogene. 11:1005–1011. 1995.PubMed/NCBI
|
|
11
|
Kong S, Amos CI, Luthra R, Lynch PM, Levin
B and Frazier ML: Effects of cyclin D1 polymorphism on age of onset
of hereditary nonpolyposis colorectal cancer. Cancer Res.
60:249–252. 2000.PubMed/NCBI
|
|
12
|
Moher D, Liberati A, Tetzlaff J and Altman
DG: Preferred reporting items for systematic reviews and
meta-analyses: The PRISMA statement. BMJ. 339:b25352009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Little J, Bradley L, Bray MS, Clyne M,
Dorman J, Ellsworth DL, Hanson J, Khoury M, Lau J, O'Brien TR, et
al: Reporting, appraising and integrating data on genotype
prevalence and gene-disease associations. Am J Epidemiol.
156:300–310. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Y, Jia Q, Xue P, Liu Y, Xiong T,
Yang J, Song C, He Q and Du L: The-786T>C polymorphism in the
NOS3 gene is associated with increased cancer risk. Tumour Biol.
35:3535–3540. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lau J, Ioannidis JP and Schmid CH:
Quantitative synthesis in systematic reviews. Ann Intern Med.
127:820–826. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mantel N and Haenszel W: Statistical
aspects of the analysis of data from retrospective studies of
disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
|
|
18
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bagos PG and Nikolopoulos GK: Generalized
least squares for assessing trends in cumulative meta-analysis with
applications in genetic epidemiology. J Clin Epidemiol.
62:1037–1044. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McKay JA, Douglas JJ, Ross VG, Curran S,
Murray GI, Cassidy J and McLeod HL: Cyclin D1 protein expression
and gene polymorphism in colorectal cancer. Aberdeen colorectal
initiative. Int J Cancer. 88:77–81. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kong S, Wei Q, Amos CI, Lynch PM, Levin B,
Zong J and Frazier ML: Cyclin D1 polymorphism and increased risk of
colorectal cancer at young age. J Natl Cancer Inst. 93:1106–1108.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bala S and Peltomäki P: Cyclin D1 as a
genetic modifier in hereditary nonpolyposis colorectal cancer.
Cancer Res. 61:6042–6045. 2001.PubMed/NCBI
|
|
23
|
Porter TR, Richards FM, Houlston RS, Evans
DG, Jankowski JA, Macdonald F, Norbury G, Payne SJ, Fisher SA,
Tomlinson I and Maher ER: Contribution of cyclin d1 (CCND1) and
E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal
cancer. Oncogene. 21:1928–1933. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Le Marchand L, Seifried A, Lum-Jones A,
Donlon T and Wilkens LR: Association of the cyclin D1 A870G
polymorphism with advanced colorectal cancer. JAMA. 290:2843–2848.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Grieu F, Malaney S, Ward R, Joseph D and
Iacopetta B: Lack of association between CCND1 G870A polymorphism
and the risk of breast and colorectal cancers. Anticancer Res.
23:4257–4259. 2003.PubMed/NCBI
|
|
26
|
Hong Y, Eu KW, Seow-Choen F, Fook-Chong S
and Cheah PY: GG genotype of cyclin D1 G870A polymorphism is
associated with increased risk and advanced colorectal cancer in
patients in Singapore. Eur J Cancer. 41:1037–1044. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang J, Wang J, Suzuki S, Gajalakshmi V,
Kuriki K, Zhao Y, Nakamura S, Akasaka S, Ishikawa H and Tokudome S:
Elevated risk of colorectal cancer associated with the AA genotype
of the cyclin D1 A870G polymorphism in an Indian population. J
Cancer Res Clin Oncol. 132:193–199. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schernhammer ES, Tranah GJ, Giovannucci E,
Chan AT, Ma J, Colditz GA, Hunter DJ, Willett WC and Fuchs CS:
Cyclin D1 A870G polymorphism and the risk of colorectal cancer and
adenoma. Br J Cancer. 94:928–934. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang WS, Tang R, Lin PY, Changchien CR,
Chen JS, Chiang JM, Yeh CY, Wang JY and Hsieh LL: Impact of the
cyclin D1 A870G polymorphism on susceptibility to sporadic
colorectal cancer in Taiwan. Dis Colon Rectum. 49:602–608. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Probst-Hensch NM, Sun CL, Van Den Berg D,
Ceschi M, Koh WP and Yu MC: The effect of the cyclin D1 (CCND1)
A870G polymorphism on colorectal cancer risk is modified by
glutathione-S-transferase polymorphisms and isothiocyanate intake
in the Singapore Chinese health study. Carcinogenesis.
27:2475–2482. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Krüger S, Engel C, Bier A, Mangold E,
Pagenstecher C, Doeberitz Mv, Holinski-Feder E, Moeslein G, Keller
G, Kunstmann E, et al: Absence of association between cyclin D1
(CCND1) G870A polymorphism and age of onset in hereditary
nonpolyposis colorectal cancer. Cancer Lett. 236:191–197. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Grünhage F, Jungck M, Lamberti C, Berg C,
Becker U, Schulte-Witte H, Plassmann D, Rahner N, Aretz S,
Friedrichs N, et al: Association of familial colorectal cancer with
variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes. Int
J Colorectal Dis. 23:147–154. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tan XL, Nieters A, Kropp S, Hoffmeister M,
Brenner H and Chang-Claude J: The association of cyclin D1 G870A
and E-cadherin C-160A polymorphisms with the risk of colorectal
cancer in a case control study and meta-analysis. Int J Cancer.
122:2573–2580. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Forones NM, de Lima JM, de Souza LG and da
Silva ID: Cyclin D1 A870G polymorphism in Brazilian colorectal
cancer patients. J Gastrointest Cancer. 39:118–123. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu B, Zhang Y, Jin M, Ni Q, Liang X, Ma
X, Yao K, Li Q and Chen K: Association of selected polymorphisms of
CCND1, p21 and caspase8 with colorectal cancer risk. Mol Carcinog.
49:75–84. 2010.PubMed/NCBI
|
|
36
|
Kanaan Z, Eichenberger MR, Young M,
Colliver D, Crawford N, Cobbs GA, Hein DW and Galandiuk S: An
alternative cyclin-D1 splice site is not linked to inflammatory
bowel disease-associated neoplasia. Int J Biol Markers. 25:27–31.
2010.PubMed/NCBI
|
|
37
|
Yaylim-Eraltan I, Arikan S, Yildiz Y,
Cacina C, Ergen HA, Tuna G, Görmüs U, Zeybek U and Isbir T: The
influence of cyclin D1 A870G polymorphism on colorectal cancer risk
and prognosis in a Turkish population. Anticancer Res.
30:2875–2880. 2010.PubMed/NCBI
|
|
38
|
Jelonek K, Gdowicz-Klosok A, Pietrowska M,
Borkowska M, Korfanty J, Rzeszowska-Wolny J and Widlak P:
Association between single-nucleotide polymorphisms of selected
genes involved in the response to DNA damage and risk of colon,
head and neck and breast cancers in a Polish population. J Appl
Genet. 51:343–352. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Talseth BA, Ashton KA, Meldrum C, Suchy J,
Kurzawski G, Lubinski J and Scott RJ: Aurora-A and Cyclin D1
polymorphisms and the age of onset of colorectal cancer in
hereditary nonpolyposis colorectal cancer. Int J Cancer.
122:1273–1277. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sameer AS, Parray FQ, Dar MA, Nissar S,
Banday MZ, Rasool S, Gulzar GM, Chowdri NA and Siddiqi MA: Cyclin
D1 G870A polymorphism and risk of colorectal cancer: A case control
study. Mol Med Rep. 7:811–815. 2013.PubMed/NCBI
|
|
41
|
Govatati S, Singamsetty GK, Nallabelli N,
Malempati S, Rao PS, Madamchetty VK, Govatati S, Kanapuram R,
Narayana N, Bhanoori M, et al: Contribution of cyclin D1 (CCND1)
and E-cadherin (CDH1) alterations to colorectal cancer
susceptibility: A case-control study. Tumour Biol. 35:12059–12067.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hall M and Peters G: Genetic alterations
of cyclins, cyclin-dependent kinases and Cdk inhibitors in human
cancer. Adv Cancer Res. 68:67–108. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Solomon DA, Wang Y, Fox SR, Lambeck TC,
Giesting S, Lan Z, Senderowicz AM, Conti CJ and Knudsen ES: Cyclin
D1 splice variants. Differential effects on localization, RB
phosphorylation and cellular transformation. J Biol Chem.
278:30339–30347. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Onay UV, Aaltonen K, Briollais L, Knight
JA, Pabalan N, Kilpivaara O, Andrulis IL, Blomqvist C, Nevanlinna H
and Ozcelik H: Combined effect of CCND1 and COMT polymorphisms and
increased breast cancer risk. BMC Cancer. 8:62008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Mandal RK and Mittal RD: Are cell cycle
and apoptosis genes associated with prostate cancer risk in North
Indian population? Urol Oncol. 30:555–561. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Casson AG, Zheng Z, Evans SC, Geldenhuys
L, van Zanten SV, Veugelers PJ, Porter GA and Guernsey DL: Cyclin
D1 polymorphism (G870A) and risk for esophageal adenocarcinoma.
Cancer. 104:730–739. 2005. View Article : Google Scholar : PubMed/NCBI
|
